Evaluating the Effectiveness of an Autism-Specific Workplace Tool for Employers: A Randomised Controlled Trial.
Melissa GroblerMarita FalkmerTorbjörn FalkmerSonya GirdlerPublished in: Journal of autism and developmental disorders (2019)
A randomised controlled trial evaluated the effectiveness of the Integrated Employment Success Tool (IEST™) in improving employers' self-efficacy in modifying the workplace for individuals on the autism spectrum. Employers (N = 84) were randomised to the IEST™ or support as usual groups. Measurements of self-efficacy, knowledge and attitudes towards disability in the workplace were obtained at baseline and post-test. Results revealed a significant improvement in self-efficacy within the IEST™ group between baseline and post-test (p = 0.016). At post-test, there were no significant differences between groups in relation to self-efficacy in implementing autism-specific workplace modifications and employer attitudes towards disability in the workplace. Given the lack of significant outcomes, further research is needed to determine the effectiveness of the IEST™ for employers. Trial registration: Australian New Zealand Clinical Trials Registry #ACTRN12614000771651, registered 21/7/2014. Trial URL https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366699 .
Keyphrases
- clinical trial
- study protocol
- phase iii
- phase ii
- randomized controlled trial
- autism spectrum disorder
- health promotion
- intellectual disability
- systematic review
- open label
- multiple sclerosis
- double blind
- healthcare
- type diabetes
- adipose tissue
- skeletal muscle
- placebo controlled
- gold nanoparticles
- reduced graphene oxide